CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Megan E. Murray, Catherine M. Gavile, Jayakumar R. Nair, Chandana Koorella, Louise M. Carlson, Daniela Buac, Adam Utley, Marta Chesi, P. Leif Bergsagel, Lawrence H. Boise, Kelvin P. Lee

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Chemotherapeutic resistance remains a significant hurdle in the treatment of multiple myeloma (MM) and is significantly mediated by interactions between MM cells and stromal cells of the bonemarrow microenvironment. Despite the importance of these interactions, the specific molecules and downstream signaling components involved remain incompletely understood. We have previously shown that the prototypic T-cell costimulatory receptor CD28, which is also expressed on MM cells, is a key mediator of MM survival and apoptotic resistance. Crosslinking CD28 by agonistic antibodies or myeloid dendritic cells (DC; these express the CD28 ligands CD80/CD86) prevents apoptosis caused by chemotherapy or serum withdrawal. We now report that CD28 pro-survival signaling is dependent upon downstream activation of phosphatidyl-inositol 3-kinase/Akt, inactivation of the transcription factor FoxO3a, and decreased expression of the pro-apoptotic molecule Bim. Conversely, blocking the CD28-CD80/CD86 interaction between MM cells and DC in vitro abrogates the DC's ability to protect MM cells against chemotherapy-induced death. Consistent with these observations, in vivo blockade of CD28-CD80/CD86 in the Vk*MYC murine myeloma model sensitizes MM cells to chemotherapy and significantly reduces tumor burden. Taken together, our findings suggest that CD28 is an important mediator of MM survival during stress and can be targeted to overcome chemotherapy resistance.

Original languageEnglish (US)
Pages (from-to)3770-3779
Number of pages10
JournalBlood
Volume123
Issue number24
DOIs
StatePublished - Jun 12 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma'. Together they form a unique fingerprint.

  • Cite this

    Murray, M. E., Gavile, C. M., Nair, J. R., Koorella, C., Carlson, L. M., Buac, D., Utley, A., Chesi, M., Bergsagel, P. L., Boise, L. H., & Lee, K. P. (2014). CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood, 123(24), 3770-3779. https://doi.org/10.1182/blood-2013-10-530964